Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
CARDIOVASCULAR THERAPY AND PREVENTION,
Journal Year:
2024,
Volume and Issue:
23(3), P. 3696 - 3696
Published: April 1, 2024
Создание
руководства
поддержано
Советом
по
терапевтическим
наукам
отделения
клинической
медицины
Российской
академии
наук.
Language: Русский
Asthma as a manifestation of post-COVID syndrome
И. В. Демко,
No information about this author
K. I. Chinyakova,
No information about this author
А. Yu. Kraposhina
No information about this author
et al.
Bulletin physiology and pathology of respiration,
Journal Year:
2025,
Volume and Issue:
95, P. 126 - 134
Published: March 20, 2025
Introduction.
One
of
the
most
common
complications
novel
coronavirus
infection
(COVID-19)
involves
respiratory
system
disorders,
particularly
bronchial
obstruction.
Aim.
To
highlight
importance
vigilance
regarding
onset
diseases,
including
asthma,
in
post-COVID
period.
Results.
This
article
describes
a
clinical
case
newly
diagnosed
severe
asthma
35-year-old
patient
following
COVID-19.
A
notable
feature
patient’s
condition
was
prolonged
eosinophilia.
Sensitization
to
inhalant
allergens
ruled
out
by
negative
Phadiatop
ImmunoCAP
screening
test.
Despite
receiving
fixed
triple
combination
an
inhaled
corticosteroid,
long-acting
β
2
agonist,
and
anticholinergic
agent,
disease
remained
uncontrolled
with
persistent
airway
genetically
engineered
biological
therapy
subsequently
prescribed,
resulting
marked
improvement.
Conclusion.
illustrates
manifestation
syndrome—new-onset
asthma.
Timely
diagnosis
enables
prompt
selection
appropriate
therapy,
improving
quality
life
facilitating
return
normal
daily
activities.
Language: Английский
Analytical review of respiratory infections role in patients with chronic obstructive pulmonary disease and asthma. Part 1. Characteristics of respiratory infections and their long-term consequences
Russian Journal of Preventive Medicine,
Journal Year:
2024,
Volume and Issue:
27(1), P. 90 - 90
Published: Jan. 1, 2024
Language: Английский
Relationship between dyspnea and respiratory function indicators after coronavirus pneumonia
А. В. Мелехов,
No information about this author
В. И. Светлаков,
No information about this author
S. A. Bedritsky
No information about this author
et al.
Bulletin physiology and pathology of respiration,
Journal Year:
2024,
Volume and Issue:
92, P. 29 - 39
Published: June 18, 2024
Aim.
To
study
the
relationship
between
probability
and
severity
of
dyspnea
following
COVID-19
pneumonia
with
characteristics
lung
ventilatory
function
(LVF),
diffusion
capacity
(DCL),
respiratory
muscle
strength
(RMS)
impairments.
Materials
methods.
A
total
108
patients
(58%
women,
age
62
[52-66]
years)
who
had
recovered
from
were
examined.
Spirometry,
bodyplethysmography,
DCL,
RMS
assessments
conducted
75
(46-155)
days
after
onset
disease.
The
was
evaluated
using
MRC
(Medical
Research
Council
Scale)
10-point
Borg
scale.
Instrumental
laboratory
data
acute
phase
retrospectively
obtained
medical
records.
Results.
risk
any
at
time
examination
statistically
significantly
higher
in
reduced
(z-score
<
-1.645)
VC,
FVC,
FEV
1
,
DLCO,
VA,
DLCO/VA.
No
correlation
found
indicators
(maximum
C-reactive
protein,
lactate
dehydrogenase
levels,
tissue
damage
assessed
by
computed
tomography,
positive
PCR
test),
sex,
or
body
mass
index.
None
a
Gensler
index
<70%;
however,
10.3%
patients.
Restrictive
LVF
impairments
observed
8.3%
patients,
mixed
11.2%.
Dyspnea
impairments,
especially
type,
compared
to
normal
biomechanics.
functional
parameters
persisted
even
when
sample
limited
(n=75)
without
comorbidities
(n=49).
In
no
did
not
report
dyspnea,
ITGV,
DLCO/VA
values
(in
%
predicted)
higher,
Raw
Rocc
lower
than
those
dyspnea.
Conclusion.
There
is
restrictive,
obstructive
VFL
DCL
post-COVID-19
period.
Additionally,
identified
patterns
suggest
that
subclinical
bronchial
obstruction
may
be
possible
mechanisms
biomechanics
pattern.
Language: Английский
Post-COVID respiratory disorders
Published: July 23, 2024
По
крайней
мере
1
симптом
респираторных
нарушений
регистрируется
через
мес.после
перенесенной
инфекции
COronaVIrus
Disease-2019
(COVID-19)
у
54%
больных,
2-5
мес.-у
55%,
≥
6
больных
[1].Респираторные
проявления
представлены
преимущественно
жалобами
на
одышку
(14-35%
случаев),
кашель
(5-40%),
боль
в
грудной
клетке
(5-29%)
и
отхождение
мокроты
(2-4%)
[2].Через
4-8
нед.после
завершения
стационарного
лечения
COVID-19
одышка
регистрировалась
65,6%
ранее
помещенных
отделении
интенсивной
терапии
(ОРИТ),
42,6%
находившихся
общей
палате
[3].Учитывая
высокий
процент
частоты
регистрируемых
жалоб
Language: Русский
Lung function in patients with asthma in the post-COVID period
Bulletin physiology and pathology of respiration,
Journal Year:
2024,
Volume and Issue:
1(93), P. 72 - 82
Published: Sept. 12, 2024
Aim
.
To
assess
the
lung
function
in
patients
with
bronchial
asthma
(BA)
after
new-onset
coronavirus
infection.
Materials
and
methods
Fifty-five
who
underwent
COVID-19
participated
study
under
conditions
of
voluntary
informed
consent.
The
main
group
consisted
30
mild
BA,
comparison
–
25
without
chronic
respiratory
diseases
(CRD).
According
to
chest
computed
tomography
(CT)
findings,
degree
parenchyma
involvement
was
classified
as
follows:
(CT
0
stage)
14
patients;
moderate
1-2
stages)
27
severe
3-4
patients.
Lung
tests
were
conducted
once,
adhering
both
Russian
international
standards.
Results
In
obstructive
pulmonary
impairment
predominant
at
CT
stages
(79%),
stage
(67%),
(43%).
diffusion
capacity
(LDC)
impaired
predominantly
BA
those
CRD,
occurring
57%
cases.
Analysis
showed
that
LDC
reduction
detected
17%
cases
24%
non-CRD
There
no
statistically
significant
changes
ventilation
among
compared
CRD.
Conclusion
All
symptoms
should
undergo
comprehensive
assessment
identify
obstruction,
capacity,
ensure
timely
intervention.
Language: Английский
Current aspects of differential diagnosis and treatment of cough
Meditsinskiy sovet = Medical Council,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 27, 2024
Cough
is
a
common
and
important
respiratory
symptom
that
can
cause
significant
complications
for
patients
be
diagnostic
challenge
physicians.
An
organized
approach
to
the
evaluation
of
cough
begins
with
classifying
it
as
acute,
subacute,
or
chronic
based
on
duration
time
onset.
Acute
(up
3
weeks)
most
often
one
main
symptoms
acute
viral
infections
bronchitis.
Subacute
cough,
lasting
from
8
weeks,
usually
postinfectious
postviral
in
origin.
Common
causes
more
than
weeks
normal
chest
X-ray
are
variant
bronchial
asthma,
obstructive
pulmonary
disease,
upper
airway
syndrome
/
postnasal
drip
syndrome,
non-asthmatic
eosinophilic
bronchitis,
gastroesophageal
reflux,
medications
(primarily
angiotensin-converting
enzyme
inhibitors).
The
spectrum
possible
diverse,
however,
pathology
comes
forefront
differential
search.
Successful
treatment
an
task
clinical
practice.
Given
multicomponent
nature
presence
catarrhal-respiratory
broncho-obstructive
syndromes
picture
along
bronchitis
combination
drugs
become
drug
choice.
In
conclusion,
possibilities
combined
(bromhexine
+
guaifenesin
salbutamol)
expectorant
against
its
effectiveness
safety
considered.
Language: Английский
Hematologic indices as an available tool in the diagnosis of adverse course of COVID-19
Terapevticheskii arkhiv,
Journal Year:
2024,
Volume and Issue:
96(11), P. 1028 - 1034
Published: Dec. 16, 2024
Aim.
To
study
the
prognostic
significance
of
hematologic
indices:
neutrophils/lymphocytes
(N/L),
platelets/lymphocytes
(P/L)
and
lymphocytes/C-reactive
protein
(L/CRP)
in
relation
to
complicated
course
new
coronavirus
infection
(COVID-19),
as
well
their
correlation
with
COVID-19
severity
indices
endothelial
dysfunction
marker
sVCAM-1.
Materials
methods.
103
patients
(COVID-19)
were
included
study.
Based
on
data
multispiral
computed
tomography
(CT)
chest
organs,
all
divided
into
3
groups:
CT
group
1
–
30
patients,
2
62
11
patients.
Results.
The
values
N/L
P/L
significantly
higher
compared
2.
L/CRP
index,
contrary,
decreased
increasing
CT-degree
lung
lesion.
concentration
sVCAM-1
was
CT-3
groups
CT-1
272.7
[267.4;
342.6]
ng/mL
212.5
[90.3;
335.6]
vs
120.0
[75.3;
189.2]
ng/mL.
Significant
correlations
studied
clinical,
laboratory
instrumental
characteristics
found.
associated
blood
(r=0.28
-0.33
respectively;
p0.05).
N/L2.53
L/CRP≤0.043
are
predictors
development
cytokine
storm
examined
Conclusion.
Hematologic
N/L,
correlated
severity,
presence
(P/L
L/CRP)
allow
predicting
(N/L
L/CRP).
Language: Английский